|
Volumn 74, Issue 4, 2009, Pages 972-976
|
Spectrofluorimetric quantification of bromazepam using a highly selective optical probe based on Eu3+-bromazepam complex in pharmaceutical and serum samples
|
Author keywords
Bromazepam; Eu3+ bromazepam complex; Luminescence enhancement; Quantification; Quantum yield
|
Indexed keywords
BROMAZEPAM;
CONCENTRATION OF;
DETECTION LIMITS;
ENHANCEMENT MECHANISM;
LUMINESCENCE ENHANCEMENT;
LUMINESCENCE ENHANCEMENTS;
LUMINESCENCE INTENSITY;
OPTICAL PROBE;
PHOSPHATE BUFFERS;
QUANTITATIVE DETECTION;
SERUM SAMPLES;
SPECTROFLUORIMETRIC;
SPECTROFLUORIMETRIC METHODS;
TRACE AMOUNTS;
WORKING RANGE;
EUROPIUM;
TRACE ANALYSIS;
LUMINESCENCE;
ANXIOLYTIC AGENT;
BROMAZEPAM;
EUROPIUM;
ARTICLE;
BLOOD;
CHEMISTRY;
ECONOMICS;
HUMAN;
METHODOLOGY;
SPECTROFLUOROMETRY;
STATISTICAL PARAMETERS;
TIME;
VALIDATION STUDY;
ANTI-ANXIETY AGENTS;
BROMAZEPAM;
EUROPIUM;
HUMANS;
LIMIT OF DETECTION;
SPECTROMETRY, FLUORESCENCE;
TIME FACTORS;
|
EID: 71749093030
PISSN: 13861425
EISSN: None
Source Type: Journal
DOI: 10.1016/j.saa.2009.09.002 Document Type: Article |
Times cited : (30)
|
References (44)
|